N-[(4-nitrophenyl)methyl]tetrahydro-N-methyl-2H-pyran-4-amine | 229007-08-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-[(4-nitrophenyl)methyl]tetrahydro-N-methyl-2H-pyran-4-amine
• 英文别名: N-(4-nitrobenzyl)-N-(tetrahydropyran-4-yl)methylamine；methyl-(4-nitrobenzyl)-(tetrahydropyran-4-yl)-amine；methyl-(4-nitro-benzyl)-(tetrahydro-pyran-4-yl)-amine；methyl(4-nitrobenzyl)tetrahydropyran-4-ylamine；N-methyl-N-[(4-nitrophenyl)methyl]oxan-4-amine
• CAS: 229007-08-3
• 化学式: C₁₃H₁₈N₂O₃
• 分子量: 250.298
• InChiKey: ACGFPZIJPPEUEQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.54
• 拓扑面积：
  58.3
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  N-[(4-nitrophenyl)methyl]tetrahydro-N-methyl-2H-pyran-4-amine 在 氢气 作用下， 以 甲醇 为溶剂， 20.0 ℃ 、101.33 kPa 条件下， 反应 1.67h， 以98%的产率得到4-[N-甲基-N-(四氢-2H-吡喃-4-基)氨基甲基]苯胺
  参考文献：
  名称：

  Hydrogenation of (N,N-disubstituted aminomethyl)nitrobenzenes to (N,N-disubstituted aminomethyl)anilines catalyzed by palladium–nickel bimetallic nanoparticles

  摘要：

  一种Pd-Ni双金属纳米颗粒催化的（N,N-二取代氨甲基）硝基苯胺加氢反应实现了对（N,N-二取代氨甲基）苯胺的化学选择性。

  DOI：

  10.1039/c5ra07208e
• 作为产物：
  描述：

  4-硝基苄胺 在 三乙酰氧基硼氢化钠 作用下， 生成 N-[(4-nitrophenyl)methyl]tetrahydro-N-methyl-2H-pyran-4-amine
  参考文献：
  名称：

  Process Development of 4-[N-Methyl-N-(tetrahydropyran-4-yl)aminomethyl]aniline Dihydrochloride:  A Key Intermediate for TAK-779, a Small-Molecule Nonpeptide CCR5 Antagonist

  摘要：

  A new and efficient synthesis of 4-[N-methyl-N-(tetrahydropyran-4-yl)aminomethyl]aniline dihydrochloride, a key intermediate for the CCR5 antagonist TAK-779, is described. Reductive alkylation of methylamine with tetrahydro-4H-pyran-4-one followed by alkylation of N-methyl-N-(tetrahydropyran-4-yl)amine with 4-nitrobenzylbromide and reduction of N-(4-nitrobenzyl)-N-(tetrahydropyran-4-yl)amine results in a 78% isolated yield from the starting materials by a scalable method, using only commercially available reagents.

  DOI：

  10.1021/op010052o

文献信息

• [EN] QUATERNARY SALT CCR2 ANTAGONISTS<br/>[FR] ANTAGONISTES DE CCR2 A BASE DE SELS QUATERNAIRES
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2006012135A1

  公开（公告）日：2006-02-02

  Quaternary salt compounds of Formula (I) or pharmaceutically acceptable forms thereof, which are CCR2 antagonists and are useful in preventing, treating or ameliorating CCR2 mediated inflammatory syndromes, disorders or diseases in a subject in need thereof.

  Formula (I)的四价盐化合物或其药学上可接受的形式，其为CCR2拮抗剂，可用于预防、治疗或改善CCR2介导的炎症综合征、疾病或症状。
• Quaternary salt CCR2 antagonists
  申请人：Lagu Bharat

  公开号：US20060293379A1

  公开（公告）日：2006-12-28

  Quaternary salt compounds of Formula (I) or pharmaceutically acceptable forms thereof, which are CCR2 antagonists and are useful in preventing, treating or ameliorating CCR2 mediated inflammatory syndromes, disorders or diseases in a subject in need thereof.

  Formula（I）的四价盐化合物或其药用可接受形式，是CCR2拮抗剂，可用于预防、治疗或改善需要的受体中介的炎症综合征、紊乱或疾病。
• Discovery of Novel, Potent, and Selective Small-Molecule CCR5 Antagonists as Anti-HIV-1 Agents:  Synthesis and Biological Evaluation of Anilide Derivatives with a Quaternary Ammonium Moiety
  作者：Mitsuru Shiraishi、Yoshio Aramaki、Masaki Seto、Hiroshi Imoto、Youichi Nishikawa、Naoyuki Kanzaki、Mika Okamoto、Hidekazu Sawada、Osamu Nishimura、Masanori Baba、Masahiko Fujino

  DOI：10.1021/jm9906264

  日期：2000.5.1

  new small-molecule CCR5 antagonists by high-throughput screening (HTS) of the Takeda chemical library using [(125)I]RANTES and CHO/CCR5 cells led to the discovery of lead compounds (A, B) with a quaternary ammonium or phosphonium moiety, which were synthesized to investigate new MCP-1 receptor antagonists. A series of novel anilide derivatives 1 with a quaternary ammonium moiety were designed, synthesized

  使用[（125）I] RANTES和CHO / CCR5细胞通过武田化学文库的高通量筛选（HTS）搜索新的小分子CCR5拮抗剂，导致发现具有四级键的先导化合物（A，B）铵或phospho部分，它们被合成以研究新的MCP-1受体拮抗剂。设计，合成并测试了一系列具有季铵部分的新型苯胺衍生物1的CCR5拮抗活性。通过优化铅化合物，我们发现N，N-二甲基-N- [4-[[[[（（2-（4-甲基苯基）-6），7-二氢-5H-苯并环庚烯-8-基]羰基]氨基]苄基]四氢邻-2 H-吡喃-4-氯化铵（1r，TAK-779），是一种高效且选择性的非肽CCR5拮抗剂，在结合试验中的IC（50）值为1.4 nM。化合物1r还抑制MAGI-CCR5细胞和PBMC中EC（50）值分别为1.2和3.7 nM的巨噬细胞（M）型HIV-1（Ba-L株）的复制。详细介绍了1r及其相关化合物的合成与构效关系。
• SYNTHESIS OF QUATERNARY SALT COMPOUNDS
  申请人：Li Xun

  公开号：US20090112003A1

  公开（公告）日：2009-04-30

  The present invention is directed to a process, having a reduced environmental impact, for preparing phenylamino substituted quaternary salt compounds that are CCR2 antagonists.

  本发明涉及一种具有减少环境影响的过程，用于制备苯基氨基取代的季铵盐化合物，这些化合物是CCR2拮抗剂。
• An Efficient and Practical Method for Highly Chemoselective Hydrogenation of Nitrobenzylamines to Aminobenzylamine Hydrochlorides
  作者：Chuanjie Cheng、Xinyan Wang、Lixin Xing、Bo Liu、Rui Zhu、Yuefei Hu

  DOI：10.1002/adsc.200600521

  日期：2007.7.2

  proved to be a very reliable modulator for adjusting the reactivity of palladium on carbon. Thus an efficient and practical method for the highly chemoselective hydrogenation of N,N-dialkylnitrobenzylamines to amino-N,N-dialkylbenzylamine hydrochlorides was established. The method features convenient performance, easy work-up and high efficiency.

  盐酸水溶液被证明是用于调节钯/碳反应性的非常可靠的调节剂。因此，建立了将N，N-二烷基硝基苄基胺高度化学选择性氢化成氨基-N，N-二烷基苄基胺盐酸盐的有效且实用的方法。该方法性能方便，后处理容易，效率高。